01105nas a2200409   4500000000100000008004100001100001400042700002700056700001500083700001300098700001500111700002100126700001300147700001700160700001100177700001700188700001600205700001600221700001600237700001300253700002000266700001600286700001500302700001200317700001600329700002400345700001700369700001600386700001800402700001600420700001500436700001600451245018900467300001000656490001500666022001400681       2016                            d1 aC. Huerta1 aV. Abbing-Karahagopian1 aG. Requena1 aB. Oliva1 aY. Alvarez1 aH. Gardarsdottir1 aM. Miret1 aC. Schneider1 aM. Gil1 aP. Souverein1 aM. De Bruin1 aJ. Slattery1 aM. de Groot1 aU. Hesse1 aM. Rottenkolber1 aS. Schmiedl1 aD. Montero1 aA. Bate1 aA. Ruigomez1 aL. Garcia-Rodriguez1 aS. Johansson1 aF. de Vries1 aR. Schlienger1 aR. Reynolds1 aO. Klungel1 aF. de Abajo00aExposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: a cross-national descriptive study from the PROTECT-EU Project  a56-650 v25 Suppl 1  a1053-8569